Illumina Inc (ILMN)

Illumina Inc (ILMN) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $40.7B; returns 1 day +0.0%, 1 week +2.6%, 1 year +169.5%.

Illumina Inc. is a global leader in genetic and genomic analysis, primarily operating through a 'razor-and-blade' business model. The company designs, manufactures, and markets integrated systems for DNA sequencing and array-based technologies.

Groups ILMN belongs to

• Shrinking Share Count
• Biotechnology
• S&P 500
• Life Sciences Tools & Services
• Healthcare
• Precision Medicine
• R&D
• Oncology
• Medical Devices
• Healthcare Technology
• Life Sciences

ILMN financial model: income statement, cash flow and balance sheet